The LAA is the leading source of stroke-causing clots in Afib. Backed by randomized clinical trial evidence and a Class IA guideline recommendation, LAAE is a critical step in reducing stroke risk when treating Afib during cardiac surgery.
Learn why: <a href="https://t.co/hS9NTYgksm" target="_blank">https://t.co/hS9NTYgksm</a>
